×
About 7,400 results

ALLMedicine Unstable Angina Center

Research & Reviews  2,667 results

Prospective randomized controlled trial study of Luofengning granule in the treatment o...
https://doi.org/10.1097/MD.0000000000020025
Medicine Wang K, Cai JJ et. al.

May 23rd, 2020 - Although the current western treatment plans for unstable angina (UA) has been optimized in past decades, UA still is a common phenotype of acute coronary syndrome and significantly influence the quality of life and endanger lives. In China, the c...

Challenges in the management of older patients with acute coronary syndromes in the COV...
https://doi.org/10.1136/heartjnl-2020-317011
Heart (British Cardiac Society); Rowland B, Kunadian V

May 21st, 2020 - Ischaemic heart disease (IHD), in particular acute coronary syndrome (ACS), comprising ST-elevation myocardial infarction, non-ST-elevation myocardial infarction and unstable angina, is the leading cause of death worldwide. Age is a major predicto...

Successful Coronary Angiography Following Rapid Intravenous Desensitization for Refract...
https://doi.org/10.1016/j.cjca.2020.02.097
The Canadian Journal of Cardiology; Khan S, Kamani A et. al.

May 15th, 2020 - Most allergic reactions to radiocontrast media can be managed with a pretreatment protocol of steroids and antihistamines. However, in rare circumstances, patients can have severe allergic symptoms despite pretreatment. In this case, we highlight ...

Myocardial Ischemic Syndromes, Heart Failure Syndromes, Electrocardiographic Abnormalit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211159
International Journal of Medical Sciences; Hung MY, Kounis NG et. al.

May 15th, 2020 - In coronary artery spasm (CAS), an excess coronary vasoconstriction causing total or subtotal vessel occlusion could lead to syncope, heart failure syndromes, arrhythmic syndromes, and myocardial ischemic syndromes including asymptomatic myocardia...

Incidentally discovered cold hemagglutinin disease with massive blood clots in the card...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216728
Journal of Cardiothoracic Surgery; Chung E, Park S et. al.

May 12th, 2020 - Cold hemagglutinin disease (CHAD) is a rare autoimmune disease, in which patients manifest symptoms when the body temperature decreases. It causes critical problems with blood clotting and hemolysis during hypothermia in cardiac surgery. Although ...

see more →

Guidelines  27 results

Depression Following Acute Coronary Syndrome Events: Screening and Treatment Guidelines from the AAFP
https://www.aafp.org/afp/2019/0615/od2.html
American Family Physician;

Jun 14th, 2019 - Purpose: To review the evidence and provide clinical recommendations for the screening and treatment of depression in patients who have had a recent acute coronary syndrome event. Methods: This guideline is based on a systematic review of randomi...

FDA Approves Praluent® (Alirocumab) To Prevent Heart Attack, Stroke And Unstable Angina Requiring Hospitalization
https://investor.regeneron.com/news-releases/news-release-details/fda-approves-praluentr-alirocumab-prevent-heart-attack-stroke

Apr 25th, 2019 - Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Praluent® (alirocumab) to reduce the risk of heart attack, stroke and unstable angina requiring hospitalization...

Reduction Of Type 1 And Type 2 Myocardial Infarctions In Patients Treated With Alirocumab: Insights From The Odyssey Trial
http://www.onlinejacc.org/content/73/9_Supplement_1/4
White,H.,et al

Feb 28th, 2019 - LDL cholesterol (LDL-C) reduction with statins and PCSK9 inhibitors reduces risk of myocardial infarction (MI), but effects on specific types of MI are unknown. ODYSSEY OUTCOMES compared the PCSK9 inhibitor alirocumab (ALI) with placebo (PBO) in 1...

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT
http://www.onlinejacc.org/content/early/2019/03/21/j.jacc.2019.02.032
Bhatt,D.,et al

Feb 28th, 2019 - Background In time-to-first-event analyses, icosapent ethyl significantly reduced the risk of ischemic events, including cardiovascular death, among patients with elevated triglycerides receiving statins. These patients are at risk for not only fi...

2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Manage...
http://www.onlinejacc.org/content/64/18/1929
Stephan D. Fihn

Oct 31st, 2014 - These guidelines are intended to apply to adult patients with stable known or suspected ischemic heart disease (IHD), including those with new-onset chest pain (i. e.

see more →

Drugs  301 results see all →

Clinicaltrials.gov  3,645 results

Prospective randomized controlled trial study of Luofengning granule in the treatment o...
https://doi.org/10.1097/MD.0000000000020025
Medicine Wang K, Cai JJ et. al.

May 23rd, 2020 - Although the current western treatment plans for unstable angina (UA) has been optimized in past decades, UA still is a common phenotype of acute coronary syndrome and significantly influence the quality of life and endanger lives. In China, the c...

Challenges in the management of older patients with acute coronary syndromes in the COV...
https://doi.org/10.1136/heartjnl-2020-317011
Heart (British Cardiac Society); Rowland B, Kunadian V

May 21st, 2020 - Ischaemic heart disease (IHD), in particular acute coronary syndrome (ACS), comprising ST-elevation myocardial infarction, non-ST-elevation myocardial infarction and unstable angina, is the leading cause of death worldwide. Age is a major predicto...

Clopidogrel - clopidogrel bisulfate tablet, film coated-American Health Packaging
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=65ea4dc6-acb2-4609-9a4c-4866ef0ccb11

May 18th, 2020 - Clopidogrel bisulfate is a P2Y12 platelet inhibitor indicated for: Acute coronary syndrome For patients with non-ST-segment elevation ACS (unstable angina [UA]/non-ST-elevation myocardial infarction [NSTEMI]), clopidogrel bisulfate has been shown ...

Successful Coronary Angiography Following Rapid Intravenous Desensitization for Refract...
https://doi.org/10.1016/j.cjca.2020.02.097
The Canadian Journal of Cardiology; Khan S, Kamani A et. al.

May 15th, 2020 - Most allergic reactions to radiocontrast media can be managed with a pretreatment protocol of steroids and antihistamines. However, in rare circumstances, patients can have severe allergic symptoms despite pretreatment. In this case, we highlight ...

Myocardial Ischemic Syndromes, Heart Failure Syndromes, Electrocardiographic Abnormalit...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211159
International Journal of Medical Sciences; Hung MY, Kounis NG et. al.

May 15th, 2020 - In coronary artery spasm (CAS), an excess coronary vasoconstriction causing total or subtotal vessel occlusion could lead to syncope, heart failure syndromes, arrhythmic syndromes, and myocardial ischemic syndromes including asymptomatic myocardia...

see more →

News  759 results

Has NICE Got It Wrong on Acute Coronary Syndromes?
https://www.medscape.com/viewarticle/925473

Feb 20th, 2020 - This transcript has been edited for clarity. My name is Mamas Mamas. I'm professor of cardiology based at Keele University. So, today we're going to talk about The National Institute for Health and Care Excellence (NICE) consultation document for ...

The ISCHEMIA Trial -- Cardiology Changes Today
https://www.medscape.com/viewarticle/921464

Nov 16th, 2019 - To Bernard Lown, MD: Sir, you are no longer a maverick. We should have listened to you. It took over 40 years, but today, at the American Heart Association (AHA) Scientific Sessions 2019, we learned that you were right to stop referring "most pati...

ISCHEMIA: PCI, Surgery Strike Out vs Meds
https://www.medscape.com/viewarticle/921463

Nov 15th, 2019 - PHILADELPHIA — Viewed by many as the last chance to determine the true value of revascularization in stable ischemic heart disease, the ISCHEMIA trial failed to show fewer major cardiovascular events with an early invasive strategy than optimal me...

Some Gain More Than Others from Alirocumab
https://www.medpagetoday.com/cardiology/dyslipidemia/81803

Aug 26th, 2019 - Patients at the highest risk derived the most benefit from aggressive lipid-lowering with PCSK9 inhibition, according to two analyses of the ODYSSEY OUTCOMES trial. Investigators previously showed that people randomized to receive alirocumab (Pral...

HsTroponin in ED Predicts Short-term CV Events
https://www.medscape.com/viewarticle/916854

Aug 13th, 2019 - Measuring high-sensitivity cardiac troponin (hs-cTn) at presentation and after 1 hour not only identifies chest pain patients in the emergency department (ED) who are having an acute myocardial infarction (AMI), but also offers good prediction of ...

see more →

Patient Education  1 results see all →